Yamaguchi et al. [18] reported that low expression of DMAP1 is related to poor prognosis in neuroblastoma patients and contributes to tumorigenesis through inhibition of ataxia telangiectasia mutated/p53 pathway activation. This evidence concerns the gene TP53 and neuroblastoma.